Use of sugammadex on burn patients: descriptive study

<sec><title>OBJECTIVES:</title><p> A burn patient is a challenge for any anesthesiologist, undergoing several surgeries during admission, and requiring general anesthesia and muscle relaxation most of the times. The victim may have respiratory system impairment and a response...

Full description

Bibliographic Details
Main Authors: Eduardo Rodríguez Sánchez M., Concepción Martínez Torres, Pablo Herrera Calo, Ignacio Jiménez
Format: Article
Language:English
Published: Sociedade Brasileira de Anestesiologia 2015-08-01
Series:Revista Brasileira de Anestesiologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942015000400240&lng=en&tlng=en
id doaj-13660aa0a3454468b65fe0b731492b8f
record_format Article
spelling doaj-13660aa0a3454468b65fe0b731492b8f2020-11-24T22:59:44ZengSociedade Brasileira de AnestesiologiaRevista Brasileira de Anestesiologia1806-907X2015-08-0165424024310.1016/j.bjane.2014.10.001S0034-70942015000400240Use of sugammadex on burn patients: descriptive studyEduardo Rodríguez Sánchez M.Concepción Martínez TorresPablo Herrera CaloIgnacio Jiménez<sec><title>OBJECTIVES:</title><p> A burn patient is a challenge for any anesthesiologist, undergoing several surgeries during admission, and requiring general anesthesia and muscle relaxation most of the times. The victim may have respiratory system impairment and a response to muscle relaxants that differs from the healthy patient, thus proper monitoring and reversal is crucial. We analyzed sugammadex effectiveness and safety in this population.</p></sec><sec><title>MATERIALS AND METHODS:</title><p> It was a prospectively descriptive study, including 4 patients, and all of them were considered major burn patients, who underwent escharotomy with general anesthesia and neuromuscular relaxation. The main variable was the time for recovery of a TOF higher than 0.9 after the administration of sugammadex before extubation.</p></sec><sec><title>RESULTS:</title><p> Mean time of recovery from a TOF ratio higher than 0.9 following the administration of Sugammadex was of 4.95 min 95% CI (3.25-6.64, <italic>p</italic>= .53).</p></sec><sec><title>CONCLUSIONS:</title><p> The reversion of neuromuscular relaxation with sugammadex appears to be effective and safe in the burn patient. More analytical, comparative studies of larger populations would be necessary to confirm these data.</p></sec>http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942015000400240&lng=en&tlng=enSugammadexCiclodextrinaQuemaduraRocuronioBoqueo neuromuscularNeostigmina
collection DOAJ
language English
format Article
sources DOAJ
author Eduardo Rodríguez Sánchez M.
Concepción Martínez Torres
Pablo Herrera Calo
Ignacio Jiménez
spellingShingle Eduardo Rodríguez Sánchez M.
Concepción Martínez Torres
Pablo Herrera Calo
Ignacio Jiménez
Use of sugammadex on burn patients: descriptive study
Revista Brasileira de Anestesiologia
Sugammadex
Ciclodextrina
Quemadura
Rocuronio
Boqueo neuromuscular
Neostigmina
author_facet Eduardo Rodríguez Sánchez M.
Concepción Martínez Torres
Pablo Herrera Calo
Ignacio Jiménez
author_sort Eduardo Rodríguez Sánchez M.
title Use of sugammadex on burn patients: descriptive study
title_short Use of sugammadex on burn patients: descriptive study
title_full Use of sugammadex on burn patients: descriptive study
title_fullStr Use of sugammadex on burn patients: descriptive study
title_full_unstemmed Use of sugammadex on burn patients: descriptive study
title_sort use of sugammadex on burn patients: descriptive study
publisher Sociedade Brasileira de Anestesiologia
series Revista Brasileira de Anestesiologia
issn 1806-907X
publishDate 2015-08-01
description <sec><title>OBJECTIVES:</title><p> A burn patient is a challenge for any anesthesiologist, undergoing several surgeries during admission, and requiring general anesthesia and muscle relaxation most of the times. The victim may have respiratory system impairment and a response to muscle relaxants that differs from the healthy patient, thus proper monitoring and reversal is crucial. We analyzed sugammadex effectiveness and safety in this population.</p></sec><sec><title>MATERIALS AND METHODS:</title><p> It was a prospectively descriptive study, including 4 patients, and all of them were considered major burn patients, who underwent escharotomy with general anesthesia and neuromuscular relaxation. The main variable was the time for recovery of a TOF higher than 0.9 after the administration of sugammadex before extubation.</p></sec><sec><title>RESULTS:</title><p> Mean time of recovery from a TOF ratio higher than 0.9 following the administration of Sugammadex was of 4.95 min 95% CI (3.25-6.64, <italic>p</italic>= .53).</p></sec><sec><title>CONCLUSIONS:</title><p> The reversion of neuromuscular relaxation with sugammadex appears to be effective and safe in the burn patient. More analytical, comparative studies of larger populations would be necessary to confirm these data.</p></sec>
topic Sugammadex
Ciclodextrina
Quemadura
Rocuronio
Boqueo neuromuscular
Neostigmina
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942015000400240&lng=en&tlng=en
work_keys_str_mv AT eduardorodriguezsanchezm useofsugammadexonburnpatientsdescriptivestudy
AT concepcionmartineztorres useofsugammadexonburnpatientsdescriptivestudy
AT pabloherreracalo useofsugammadexonburnpatientsdescriptivestudy
AT ignaciojimenez useofsugammadexonburnpatientsdescriptivestudy
_version_ 1725643967605768192